Author: HP McLovincraft

Seeker of rabbit holes. Pessimist. Libertine. Contrarian. Your huckleberry. Possibly true tales of sanity-blasting horror also known as abject reality. Prepare yourself. Veteran of a thousand psychic wars. I have seen the fnords. Deplatformed on Tumblr and Twitter.

Without ‘Much More Aggressive Shutdowns,’ The New York Times Warns, COVID-19 Could Kill ‘Well Over a Million’ Americans

Without “much more aggressive shutdowns,” a New York Times editorial warns, “well over a million” Americans “may ultimately die” from COVID-19. The paper does not cite a source for that estimate, which seems highly implausible based on the death toll so far, projections for the next few months, the gap between total infections and confirmed cases, and a crude case fatality rate that continues to fall.

Independent data scientist Youyang Gu, who has a good track record of predicting COVID-19 fatalities, is currently projecting about 231,000 deaths in the United States by November 1. The University of Washington’s Institute for Health Metrics and Evaluation projects 295,000 deaths by December 1. Assuming those projections prove to be about right, the Times is predicting that the death toll will quadruple during the months before an effective vaccine can be deployed, which might happen early next year.

Keep reading

Abortion opponents protest COVID-19 vaccines’ use of fetal cells

Senior Catholic leaders in the United States and Canada, along with other antiabortion groups, are raising ethical objections to promising COVID-19 vaccine candidates that are manufactured using cells derived from human fetuses electively aborted decades ago. They have not sought to block government funding for the vaccines, which include two candidate vaccines that the Trump administration plans to support with an investment of up to $1.7 billion, as well as a third candidate made by a Chinese company in collaboration with Canada’s National Research Council (NRC). But they are urging funders and policymakers to ensure that companies develop other vaccines that do not rely on such human fetal cell lines and, in the United States, asking the government to “incentivize” firms to only make vaccines that don’t rely on fetal cells.

Keep reading